Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients

Pneumonia Due to Pseudomonas aeruginosa

(2011) Shigeki Fujitani et al.   CHEST

Pneumonia Due to Pseudomonas aeruginosa

(2011) Hsin-Yun Sun et al.   CHEST

Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality

(2011) M. TUMBARELLO et al.   EPIDEMIOLOGY AND INFECTION

Severity of ICU-acquired pneumonia according to infectious microorganisms

(2011) Pierre Damas et al.   INTENSIVE CARE MEDICINE

Identifying new risk factors for Pseudomonas aeruginosa pneumonia in intensive care units: experience of the French national surveillance, REA-RAISIN

(2011) A.G. Venier et al.   JOURNAL OF HOSPITAL INFECTION

Costs of Bloodstream Infections Caused by Escherichia coli and Influence of Extended-Spectrum- -Lactamase Production and Inadequate Initial Antibiotic Therapy

(2010) M. Tumbarello et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Impact of Multidrug-Resistant Pseudomonas aeruginosa Bacteremia on Patient Outcomes

(2010) V. H. Tam et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Microbial Etiologies of Hospital‐Acquired Bacterial Pneumonia and Ventilator‐Associated Bacterial Pneumonia

(2010) Ronald N. Jones   CLINICAL INFECTIOUS DISEASES

Inappropriate antibiotic therapy in Gram-negative sepsis increases hospital length of stay*

(2010) Andrew F. Shorr et al.   CRITICAL CARE MEDICINE

In vivo development of antimicrobial resistance in Pseudomonas aeruginosa strains isolated from the lower respiratory tract of Intensive Care Unit patients with nosocomial pneumonia and receiving antipseudomonal therapy

(2010) Mickaël Riou et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Attributable Hospital Cost and Length of Stay Associated with Health Care-Associated Infections Caused by Antibiotic-Resistant Gram-Negative Bacteria

(2009) P. D. Mauldin et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Inappropriate therapy for methicillin-resistant Staphylococcus aureus: Resource utilization and cost implications*

(2009) Andrew F. Shorr et al.   CRITICAL CARE MEDICINE

Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008

(2009) R Phillip Dellinger et al.   CRITICAL CARE MEDICINE

Persistent Infection withPseudomonas aeruginosain Ventilator-associated Pneumonia

(2008) Ali A. El Solh et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Multidrug-Resistant Pseudomonas aeruginosa Ventilator-Associated Pneumonia: The Role of Endotracheal Aspirate Surveillance Cultures

(2008) Katherine Yang et al.   ANNALS OF PHARMACOTHERAPY

Predictors of 30-Day Mortality and Hospital Costs in Patients With Ventilator-Associated Pneumonia Attributed to Potentially Antibiotic-Resistant Gram-Negative Bacteria

(2008) Katherine E. Kollef et al.   CHEST

Defining, treating and preventing hospital acquired pneumonia: European perspective

(2008) Antoni Torres et al.   INTENSIVE CARE MEDICINE

Impact of inappropriate antibiotic therapy on mortality in patients with ventilator-associated pneumonia and blood stream infection: A meta-analysis

(2008) Effie L. Kuti et al.   JOURNAL OF CRITICAL CARE

Ventilator-associated pneumonia caused by multidrug-resistant organisms or Pseudomonas aeruginosa: Prevalence, incidence, risk factors, and outcomes

(2008) Chris M. Parker et al.   JOURNAL OF CRITICAL CARE